In a pregnant patient with a fasting plasma glucose of 118 mg/dL on insulin glargine (Lantus) 60 units daily, how many units should the basal insulin be increased?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Basal Insulin Dose Adjustment for Elevated Fasting Glucose in Pregnancy

Increase the Lantus dose by 10–20% (6–12 units) immediately to a total of 66–72 units, then continue titrating upward by 2–4 units every 2–3 days until fasting glucose consistently falls below 95 mg/dL. 1

Why This Fasting Glucose Requires Action

  • A fasting glucose of 118 mg/dL exceeds the American Diabetes Association target of <95 mg/dL for pregnant women with pre-existing diabetes 2, 1, 3
  • The American College of Obstetricians and Gynecologists sets an even stricter fasting target of <90 mg/dL 1
  • Fasting hyperglycemia in pregnancy is directly associated with macrosomia, neonatal hypoglycemia, and other adverse perinatal outcomes 2

Specific Titration Algorithm

Initial adjustment:

  • Raise the current 60-unit Lantus dose by 10–20%, which equals 6–12 units, bringing the total to 66–72 units 1
  • This immediate increase addresses the current hyperglycemia without risking severe hypoglycemia 1

Ongoing titration:

  • After the initial increase, continue adding 2–4 units every 2–3 days based on daily fasting glucose measurements 1
  • The goal is to achieve fasting glucose consistently <95 mg/dL 2, 1, 3
  • During the second and third trimesters, insulin resistance rises exponentially, often requiring weekly or bi-weekly dose escalations; total daily insulin may double or triple by week 36 1
  • Insulin requirements typically increase at a rate of approximately 5% per week through week 36 1

Essential Monitoring Requirements

  • Measure fasting glucose every morning and perform 4–6 blood glucose checks per day (fasting plus 1-hour or 2-hour postprandial after each meal) 2, 1
  • Target 1-hour postprandial <140 mg/dL or 2-hour postprandial <120 mg/dL 2, 1, 3
  • Check A1C monthly with a target <6% if achievable without significant hypoglycemia, or <7% if hypoglycemia risk is high 2, 1, 3
  • A1C is a secondary metric in pregnancy because increased red blood cell turnover physiologically lowers A1C and may miss postprandial spikes that drive fetal macrosomia 1, 3

Critical Consideration: Prandial Insulin Coverage

  • Basal insulin alone does not control postprandial glucose excursions 1
  • If postprandial values exceed targets despite optimized basal insulin, add rapid-acting insulin (lispro or aspart) before each meal 1
  • The American College of Obstetricians and Gynecologists recommends allocating a greater proportion of total daily insulin to prandial doses during pregnancy 1

Red-Flag Situations Requiring Urgent Evaluation

  • A sudden, unexplained drop in insulin requirements may indicate placental insufficiency and warrants immediate obstetric assessment 1, 4
  • First-trimester hypoglycemia risk is highest due to increased insulin sensitivity; comprehensive hypoglycemia education for the patient and family is mandatory before escalating insulin 1, 4

Multidisciplinary Referral

  • Refer promptly to a specialized diabetes-and-pregnancy center for coordinated care involving maternal-fetal medicine, endocrinology, diabetes education, and nutrition 1, 4
  • The complexity of insulin management in pregnancy—with rapidly changing insulin resistance and strict glycemic targets—requires team-based care for optimal maternal and fetal outcomes 1, 4

References

Guideline

Insulin Management in Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Target Blood Sugar Levels in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Diabetes in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the guidelines for managing diabetes in pregnancy?
In a pregnant patient with a fasting plasma glucose of 118 mg/dL on Lantus (insulin glargine) 60 units, how many units should the Lantus dose be increased?
What is the recommended insulin dose for a pregnant diabetic patient?
In a pregnant woman with gestational diabetes, how many out-of-parameter glucose readings qualify for initiation of insulin therapy?
What is the management plan for a pregnant patient at 36 weeks gestation with impaired glucose regulation (elevated glucose level)?
In a hypertensive patient with a systolic blood pressure difference greater than 10 mm Hg between the right and left arms, how significant is this finding, how should it be evaluated, and what is the recommended management?
What should be done for a 57-year-old woman with a cat bite, who received tetanus prophylaxis one year ago, is taking amoxicillin 500 mg twice daily (one day of therapy remaining) and thromcelin three times daily, and has persistent erythema at the bite site after nine days?
Can an adult patient with chronic full‑body muscle hypertonicity (jaw/TMJ, neck, shoulders, upper back) persisting during sleep, anxiety, racing thoughts, fragmented PAP‑treated obstructive sleep apnea, and seizure disorder controlled with lamotrigine benefit from gabapentin or pregabalin (Lyrica)?
What are the appropriate alternatives to tadalafil for an adult with erectile dysfunction or pulmonary arterial hypertension, including dosing, contraindications, and cost considerations?
What does an isolated Immunoglobulin G (IgG) p58 band on a Lyme disease Western blot indicate, and how should it be interpreted and managed?
How should rheumatoid arthritis be treated in a patient with chronic kidney disease (any stage)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.